Fake EFF Website Was Malicious, WIPO Panel Rules

A cybersquatter based in Indonesia who created a website falsely using the Electronic Frontier Foundation name but offering malware did so in bad faith and with malicious intent, a World Intellectual Property Organization panellist has found.

WTO Discussions On Non-Violation Complaints Might Be Near Consensus, Sources Say

Last month, the World Trade Organization committee on intellectual property was suspended over two contentious items. One item left open is the proposed extension of a moratorium which leaves intellectual property outside of a mechanism through which one WTO member can go after another despite no violation of a WTO agreement. According to sources, a solution might be within reach.

New Proposal For Inclusion Of Disclosure Requirement In Design Treaty; Group B Still Not Takers

The draft text of a treaty to help international designers apply for protection has been on the table at the World Intellectual Property Organization for some time, and has been under discussion again this week. Two questions have prevented its completion. One is whether technical assistance for developing countries should be part of the text, and the other is how to accommodate a request for a provision allowing countries to ask for disclosure of the origin of the design, to prevent misappropriation.

WHO Member State Mechanism On Fake Medicines Meeting This Week

This week the World Health Organization member state mechanism on falsified medicines is meeting in Geneva with a long agenda. In particular, the meeting is expected to consider a process for the mechanism review, the participation of the WHO in a global committee on the quality of health products, and several proposals including tracking systems and awareness campaigns.

Internet Governance Forum: Ten Years After

Ten years after feeble beginnings, the Internet Governance Forum, once the baby of the United Nations World Summit on the Information Society (WSIS), stood last week in Joao Pessoa. But in all these years, did it also learn to walk? The IGF is more popular than ever but also perhaps more inadequate than ever at containing and advancing the many views and concerns that are raised there by a multitude of global stakeholders.

WIPO Committee On Development And IP Agrees On Work Programme

Delegates at the World Intellectual Property Organization Committee on Development and IP (CDIP) ended a weeklong session agreeing on a programme of work for the next session including two future projects to be reconsidered. But this belies the degree of stasis and frustration in the committee.

WIPO Innovation Panel: Low Economic Growth Not The ‘New Normal’ For Long

Consensus emerged among a panel of top economists last week at the World Intellectual Property Organization that as economies become increasingly intangible they are more susceptible to repercussions on growth caused by a financial crisis. Yet the shift towards a knowledge economy brings with it promise of increased economic growth in the long term, they said.

Geographical Indications, Design Law Treaty Up Next At WIPO

The controversial issue of geographical indications returns to the World Intellectual Property Organization stage this week, as the WIPO trademark committee is expected to consider a new document put forward by the United States, and a proposal from France. The meeting comes just weeks after GIs dominated the annual WIPO General Assembly, nearly leading to suspension of the UN agency’s budget before an all-night session ended in agreement there.

Also on the agenda next week is a potential treaty on industrial designs that could be on its way to a final treaty negotiation (diplomatic conference) in 2017.

WHO Director Questions IP Rights, Drug Prices, Industry Influence

Saying she could speak more freely outside of the World Health Organization, WHO Director General Margaret Chan today told a gathering of think tank representatives at the Graduate Institute of Geneva that intellectual property rights may be unfairly driving up drug prices and that industry lobbying may be interfering with governments' efforts to take action on behalf of their citizens' public health.